Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Characterization of glycidol-hemoglobin adducts as biomarkers of exposure and in vivo dose
Stockholm University, Faculty of Science, Department of Materials and Environmental Chemistry (MMK).
2014 (English)In: Toxicology and Applied Pharmacology, ISSN 0041-008X, E-ISSN 1096-0333, Vol. 275, no 3, 213-220 p.Article in journal (Refereed) Published
Abstract [en]

Hemoglobin adducts have been used as biomarkers of exposure to reactive chemicals. Glycidol, an animal carcinogen, has been reported to form N-(2,3-dihydroxy-propyl)valine adducts to hemoglobin (diHOPrVal). To support the use of these adducts as markers of glycidol exposure, we investigated the kinetics of diHOPrVal formation and its elimination in vitro and in vivo. Five groups of rats were orally administered a single dose of glycidol ranging from 0 to 75 mg/kg bw, and diHOPrVal levels were measured 24 h after administration. A dose-dependent increase in diHOPrVal levels was observed with high linearity (R-2 = 0.943). Blood sampling at different time points (1, 10, 20, or 40 days) from four groups administered glycidol at 12 mg/kg bw suggested a linear decrease in diHOPrVal levels compatible with the normal turnover of rat erythrocytes (life span, 61 days), with the calculated first-order elimination rate constant (k(el)) indicating that the diHOPrVal adduct was chemically stable. Then, we measured the second-order rate constant (k(val)) for the reaction of glycidol with N-terminal valine in rat and human hemoglobin in in vitro experiments with whole blood. The k(val) was 6.7 (+/-) 1.1 and 5.6 +/- 1.3 (pmol/g globin per mu Mh) in rat and human blood, respectively, indicating no species differences. In vivo doses estimated from k(val) and diHOPrVal levels were in agreement with the area under the (concentration-time) curve values determined in our earlier toxicokinetic study in rats. Our results indicate that diHOPrVal is a useful biomarker for quantification of glycidol exposure and for risk assessment.

Place, publisher, year, edition, pages
2014. Vol. 275, no 3, 213-220 p.
Keyword [en]
Glycidol, Hemoglobin adducts, Toxicokinetics, In vivo dose, Exposure assessment
National Category
Chemical Sciences
Identifiers
URN: urn:nbn:se:su:diva-102959DOI: 10.1016/j.taap.2014.01.010ISI: 000333320700003OAI: oai:DiVA.org:su-102959DiVA: diva2:714852
Note

AuthorCount:4;

Available from: 2014-04-29 Created: 2014-04-25 Last updated: 2017-12-05Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Törnqvist, Margareta
By organisation
Department of Materials and Environmental Chemistry (MMK)
In the same journal
Toxicology and Applied Pharmacology
Chemical Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 24 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf